Applied Budget Impact Analysis (BIA) for NUPCO Public Tenders (Pharmaceuticals)

(Pharmaceuticals) NUPCO and the autonomous regional health clusters increasingly demand evidence of long-term financial sustainability before adopting new therapies onto formularies. This applied program masters Budget Impact Analysis (BIA), the primary instrument for demonstrating affordability over the SFDA-mandated two-to-five-year horizon. Moving beyond theoretical health economics, participants build dynamic BIA models that incorporate local Saudi epidemiology, target population demographics, and standard-of-care displacement metrics that quantify the legacy costs eliminated when a new therapy is adopted. Through interactive scenario analysis, participants model market penetration rates and calculate their financial impact on regional cluster budgets. The curriculum trains professionals to translate complex economic outputs into clear affordability narratives for macro-purchasers like NUPCO. By mastering applied BIA, participants learn to shift the procurement conversation away from unit cost toward long-term systemic savings, enabling their organizations to defend premium pricing for innovative assets and to position therapies as fiscally responsible investments within fixed cluster budgets.